1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
HASS Corp.

HASS Corp.

KKRX:450330
4,440.00
KRW
+10.00
(+0.23%)
-19.10EPS
41.05BMarket Cap
HASS Corp.
KRX:450330
(Korea Stock Exchange)

Recent

price

4,440.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
KRW
2,198.94
2,555.12
2,706.34
2,337.18
2,079.27
1,982.91
Revenue per Share
272
453
303
259
194
-19.3
Basic EPS, GAAP
-236.46
-248
-1,165.22
-360.83
-51.3
-39.93
Free Cash Flow per Basic Share
- -
- -
- -
- -
68.75
- -
Dividend per Share
983.49
1,398.45
1,933.5
5,800.89
5,920.7
5,303.79
Book Value per Share
939.26
1,335.84
1,848.92
5,686.95
5,756.72
5,127.34
Tangible Book Value per Share
6
6
6
7
8
8
Basic Weighted Avg Shares
12,596
14,910
16,039
16,165
16,591
16,085
Sales/Revenue/Turnover
13.76
19.41
10.06
7.66
5.44
-4.96
Operating Margin (%)
581
850
1,108
1,358
1,720
1,894
Depreciation Expense
1,558
2,643
1,796
1,791
1,548
-157
Net Income, GAAP
14.81
12.28
- -
- -
- -
- -
Effective Tax Rate (%)
12.37
17.73
11.2
11.08
9.33
-0.97
Profit Margin (%)
-475
728
-1,678
16,062
20,579
15,721
Working Capital
2,316
2,837
3,826
1,888
1,266
1,234
LT Debt
7,707
10,958
15,151
45,456
46,384
41,551
Total Equity
- -
16.34
- -
- -
- -
- -
Return on Invested Capital (%)
- -
18.51
- -
- -
- -
- -
Return on Capital (%)
- -
28.33
13.76
5.91
3.37
-0.36
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
5,476
5,517
5,526
LT Borrowings
1,189
1,048
1,207
LT Finance Leases
77
50
27
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
49,120
51,784
41,051

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
27,286
24,304
22,940
Cash, Cash Equivalents & STI
19,672
16,096
14,538
Accounts Receivable, Net
1,948
1,922
1,819
Inventories
4,755
5,181
5,513
Total Current Liabilities
6,707
7,552
7,220
Payables & Accruals
- -
- -
- -
ST Debt
5,476
5,517
5,526
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
2.04%
Free Cash Flow
- -
- -
-83.6%
Net Income, GAAP
- -
- -
-13.59%
Sales/Revenue/Turnover
- -
- -
2.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,328
4,076
3,350
4,411
16,165
2025
3,334
4,608
4,831
3,817
16,591
2026
3,318
4,118
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
111
29
-12
130.77
259
2025
-97
126
39
124.25
194
2026
-110.09
-71
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
68.75
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
Medtronic plc. (NYSE:MDT)
Business
HASS Corp (450330.KQ) manufactures and sells dental medical devices and restorative materials, specializing in lithium disilicate and glass-ceramic products for CAD/CAM and heat-pressing systems used by dental professionals and technicians worldwide. The company offers CAD/CAM blocks such as Amber Mill, a machinable dental glass-ceramic block made of lithium disilicate; Amber Mill Direct, a CAD/CAM-based millable lithium disilicate block; Amber Mill H, a CAD/CAM block using nano-crystalline ceramics particles; Amber Mill Q, an implant abutment solution; and Amber Mill Meso, a lithium disilicate-based block for implant prosthetics; along with heat-pressing systems including Amber Press and Amber Press Master, lithium disilicate-based press ingots; Amber LiSi-POZ and Amber LiSi-POM, lithium disilicate-based press-on-zirconia ingots; Amber Vest, an ultra-fine phosphate-bound investment for pressable dental ceramics; and additional solutions like COCO Lux, a mobile dental photography tool; Selection Tip, a shade-matching solution; and Amber Glow, a polish for zirconia, lithium disilicate, porcelain, and composites. Founded in 2008 and headquartered in Gangneung-si, South Korea, HASS operates production facilities in Gangneung with research and sales offices in Gwangmyeong, Gyeonggi-do, and maintains international subsidiaries including HASS Bio America in the United States and branches in Europe to serve customers in over 40 countries. Recent developments include the global launch of expanded sizes and shades for Amber Mill H blocks and discs to enhance customized dental solutions; strategic partnerships with imes-icore and pritidenta for the first lithium-disilicate disk milling solution; and ongoing innovation with the planned early 2026 release of Amber Mill Abut-crown, an all-ceramic implant crown block featuring a zirconia insert and titanium link for one-day procedures.